Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
US12071442B2 · kind B2 · utility
0Cited by
18References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 29, 2022 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Mar 29, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds of formula I, compositions thereof, and methods of using the same for the inhibition of HPK1, and the treatment of HPK1-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.